Trial Profile
A Phase I Clinical and Pharmacokinetic Evaluation of LY293111 in Patients With Solid Tumors (Protocol H6H-MC-JEAI).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Feb 2010
Price :
$35
*
At a glance
- Drugs Etalocib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Oct 2005 New trial record.